Crispr Therapeutics shares owned by Valiant Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Valiant Capital Management
from 13F filings
Historical chart of Valiant Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Valiant Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Valiant Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-06-30 | $13M | 229k | 56.14 |
| 2023-03-31 | $10M | 229k | 45.23 |
| 2022-12-31 | $9.3M | 229k | 40.65 |
| 2022-09-30 | $12M | 190k | 65.35 |
| 2022-06-30 | $20M | 324k | 60.77 |
| 2022-03-31 | $15M | 241k | 62.77 |
| 2021-12-31 | $14M | 178k | 75.78 |
| 2021-09-30 | $34M | 308k | 111.93 |
| 2021-06-30 | $50M | 308k | 161.89 |
| 2021-03-31 | $38M | 308k | 121.85 |
| 2020-12-31 | $54M | 355k | 153.11 |
| 2020-09-30 | $39M | 468k | 83.64 |
| 2020-06-30 | $34M | 468k | 73.49 |
| 2020-03-31 | $20M | 468k | 42.41 |
| 2019-12-31 | $17M | 272k | 60.91 |
| 2019-09-30 | $11M | 272k | 40.99 |
| 2019-06-30 | $13M | 272k | 47.10 |
| 2019-03-31 | $9.7M | 272k | 35.72 |
| 2018-12-31 | $7.8M | 272k | 28.57 |
| 2018-09-30 | $12M | 272k | 44.35 |
More positions owned by Valiant Capital Management
View all positions for Valiant Capital Management